Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ACADEMY OF SLEEP MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2023 · first_quarter · Q1
Issues impacting sleep health and sleep health physicians and other sleep professionals and sleep health patients, including education about the importance of sleep health to overall health and general well-being and issues relating to seasonal time changes, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Issues impacting sleep health and sleep health physicians and other sleep professionals and sleep health patients, including education about the importance of sleep health to overall health and general well-being and issues relating to seasonal time changes, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Source: Senate LDA
| INTERMOUNTAIN HEALTH |
| 20 |
| 1999–2010 |
| HOSPITAL SISTERS HEALTH SYSTEM | 19 | 2010–2014 |
| Champlain Valley Physicians Hospital Medical Center | 14 | 2006–2010 |
| HOSPITAL GEOGRAPHIC FAIRNESS COALITION | 14 | 2008–2011 |
| MEDICARE DEPENDENT RURAL HOSPITAL COAILTION | 12 | 2011–2014 |
| ROCHE DIAGNOSTICS CORPORATION, INC. | 12 | 2008–2015 |
| BALL MEMORIAL HOSPITAL | 11 | 2007–2010 |
| HEALTHLAND | 11 | 2012–2014 |
| TRINITY HEALTH | 11 | 2012–2014 |
| PROTHROMBIN-TIME SELF TESTING COALITION | 10 | 2008–2011 |
| ALLERGAN, INC. | 9 | 1999–2010 |
| REDPATH INTEGRATED PATHOLOGY INC | 9 | 2008–2010 |
| ST VINCENT'S MEDICAL CENTER | 9 | 2002–2007 |
| AETREX WORLDWIDE INC | 8 | 2000–2007 |
| AMERICAN ASSN OF AMBULATORY SURGERY CENTERS | 8 | 1999–2004 |
| CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION | 8 | 2013–2015 |
| Cookeville Regional Medical Center | 8 | 2007–2008 |
| HALIFAX REGIONAL MEDICAL CENTER | 8 | 2003–2006 |
| MEDCENTRAL HEALTH SYSTEM | 8 | 1999–2005 |
| AMERICAN GASTROENTROLOGICAL ASSN | 7 | 1999–2003 |
| OUTPATIENT OPHTHALMIC SURGERY SOCIETY | 7 | 1999–2003 |
| AMERICAN SPECIALTY HEALTH, INC. | 6 | 2009–2010 |
| HEALTH MANAGEMENT ASSOCIATES, INC. | 6 | 2009–2010 |
| AMERICAN ACADEMY OF SLEEP MEDICINE | 5 | 2022–2023 |
| DOMINATING HOSPITAL COALITION | 5 | 2003–2004 |
| NOVAVISION INC | 5 | 2006–2008 |
| Pocono Medical Center | 5 | 2005–2007 |
| ABBOTT LABORATORIES | 4 | 2011–2015 |
| BINGHAM MEMORIAL HOSPITAL | 4 | 2013–2014 |
| MERCY HEALTH PARTNERS | 4 | 2010 |
| SURGICAL CARE AFFILIATES | 4 | 2008 |
| ALICE HYDE MEDICAL CENTER | 3 | 2011 |
| DRUGS OF ABUSE TESTING COALITION | 3 | 2011 |
| MARSHFIELD CLINIC | 3 | 1999 |
| PHYSICIAN FEE SCHEDULE PATHOLOGY PAYMENT COALITION | 3 | 2013–2015 |
| STAMFORD HOSPITAL | 3 | 2001–2002 |
| UNITED REGIONAL HEALTH CARE SYSTEM | 3 | 2015 |
| ARTHROSCOPY ASSN OF NORTH AMERICA | 2 | 1999–2000 |
| BG MEDICINE | 2 | 2013 |
| INOVISE MEDICAL, INC. | 2 | 2007 |
| ST MARYS HOSPITAL & MEDICAL CENTER | 2 | 2005 |
| TEARLAB CORP | 2 | 2011 |
| WESTERN MONTANA CLINIC | 2 | 2013 |
| AMERICAN SOCIETY OF ECHOCARDIOGRAPHY | 1 | 2000 |
| ASSN OF FREESTANDING RADIATION ONCOLOGISTS | 1 | 2000 |
| ASSN OF PERIOPERATIVE REGISTERED NURSES | 1 | 2002 |
| CYTOMEDIX, INC. | 1 | 2008 |
| INTERNATIONAL HEARING SOCIETY | 1 | 2007 |
| MARION GENERAL HOSPITAL | 1 | 2004 |
| NEW HAMPSHIRE HOSPITAL ASSOCIATION | 1 | 2008 |
| RESPIRATORY MEDICATION PROVIDERS COALITION | 1 | 1999 |
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051, H.R. 3590.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444, H.R. 3590
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051, H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444, H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Superfund Polluter Pays Act
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Superfund Polluter Pays Act
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Sole Community Hospital Preservation Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status; seeking to advance H.R. 1051.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
340B Program Improvement and Integrity Act of 2009
Client: RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION · Firm: MCDERMOTT WILL & SCHULTE LLP
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: REDPATH INTEGRATED PATHOLOGY, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Medicare reimbursement for clinical laboratory services; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF SLEEP MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2022 · fourth_quarter · Q4
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF SLEEP MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2022 · fourth_quarter · Q4
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF SLEEP MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2022 · fourth_quarter · Q4
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF SLEEP MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2022 · fourth_quarter · Q4
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Issues impacting sleep health and sleep health physicians and other sleep professionals, including issues relating to seasonal time changes, the coronavirus and future pandemic response, telehealth, health care quality, efforts to improve health outcomes, and access to effective treatment for sleep disorders including obstructive sleep apnea, including the recall of certain PAP and ventilator devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED REGIONAL HEALTH CARE SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2015 · fourth_quarter · 4T
Payment for hospital services under the TRICARE program.
Payment for hospital services under the TRICARE program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHYSICIAN FEE SCHEDULE PATHOLOGY PAYMENT COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · fourth_quarter · 4T
Medicare reimbursement for laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · fourth_quarter · 4T
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2015 · fourth_quarter · 4T
Issues concerning regulation of laboratory tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UNITED REGIONAL HEALTH CARE SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2015 · third_quarter · Q3
Payment for hospital services under the TRICARE program.
Payment for hospital services under the TRICARE program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHYSICIAN FEE SCHEDULE PATHOLOGY PAYMENT COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · third_quarter · Q3
Medicare reimbursement for laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · third_quarter · Q3
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2015 · third_quarter · Q3
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
FDA regulation of laboratory-developed tests.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
UNITED REGIONAL HEALTH CARE SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2015 · third_quarter · RR
Payment for hospital services under the TRICARE program.
Payment for hospital services under the TRICARE program.
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · second_quarter · Q2
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2015 · second_quarter · Q2
FDA regulation of laboratory-developed tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ABBOTT LABORATORIES via MCDERMOTT WILL & SCHULTE LLP
2015 · second_quarter · Q2
Issues affecting Medicare coverage and reimbursement for medical devices and diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2015 · first_quarter · Q1
Medicare regulation of clinical laboratories.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · first_quarter · Q1
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2015 · first_quarter · Q1
FDA regulation of laboratory-developed tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2015 · first_quarter · Q1
Medicare reimbursement for laboratory tests.
Issues concerning regulation of laboratory tests.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · 1A
Medicare competitive bidding program for durable medical equipment and supplies. Medicare payments for laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · fourth_quarter · Q4
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2014 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2014 · fourth_quarter · Q4
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · fourth_quarter · Q4
Issues concerning regulation of laboratory tests.
Medicare reimbursement for laboratory tests.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2014 · third_quarter · Q3
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · third_quarter · Q3
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2014 · third_quarter · Q3
FDA regulation of laboratory-developed tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · third_quarter · Q3
Issues concerning regulation of laboratory tests.
Medicare reimbursement for laboratory tests.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · 2T
Medicare and Medicaid payments to hospitals.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · 2T
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · Q2
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · Q2
FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · Q2
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · Q2
FDA regulation of laboratory-developed tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · second_quarter · Q2
Medicare reimbursement for laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare competitive bidding program for durable medical equipment and supplies. Medicare payments for laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare and Medicaid payments to hospitals.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · 1T
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · 1T
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Issues affecting hospital systems, including delivery system reform.
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
FDA regulation of laboratory-developed tests.
Issues concerning regulation of laboratory tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare reimbursement for laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BINGHAM MEMORIAL HOSPITAL via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Medicare critical access hospital status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLEGIANCE HEALTH via MCDERMOTT WILL & SCHULTE LLP
2014 · first_quarter · Q1
Proposed regulations and legislation concerning long-term care hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WESTERN MONTANA CLINIC via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare electronic health record incentive payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Issues affecting hospital systems, including delivery system reform.
Medicare and Medicaid payments to hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Issues affecting hospital systems, including delivery system reform.
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Issues concerning regulation of laboratory tests.
FDA regulation of laboratory-developed tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Medicare reimbursement for laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BINGHAM MEMORIAL HOSPITAL via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Medicare critical access hospital status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLEGIANCE HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · fourth_quarter · Q4
Proposed regulations and legislation concerning long-term care hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WESTERN MONTANA CLINIC via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · RR
Medicare electronic health record incentive payments.
PHYSICIAN FEE SCHEDULE PATHOLOGY PAYMENT COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · RR
Medicare reimbursement for laboratory tests.
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare reimbursement for laboratory tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · RR
Medicare reimbursement for laboratory tests.
BG MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare reimbursement matters concerning diagnostic laboratory test services under the Clinical Laboratory Fee Schedule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BG MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · RR
Medicare reimbursement matters concerning diagnostic laboratory test services under the Clinical Laboratory Fee Schedule
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare and Medicaid payments to hospitals.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Issues concerning regulation of laboratory tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BINGHAM MEMORIAL HOSPITAL via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Medicare critical access hospital status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLEGIANCE HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · Q3
Proposed regulations and legislation concerning long-term care hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Medicare competitive bidding program for durable medical equipment and supplies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLEGIANCE HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Proposed regulations and legislation concerning long-term care hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BINGHAM MEMORIAL HOSPITAL via MCDERMOTT WILL & SCHULTE LLP
2013 · third_quarter · RR
Medicare critical access hospital status.
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Issues affecting hospital systems, including delivery system reform.
Medicare and Medicaid payments to hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Issues affecting hospital systems, including delivery system reform.
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
FDA regulation of laboratory-developed tests.
Issues concerning regulation of laboratory tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2013 · second_quarter · Q2
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Medicare and Medicaid payments to hospitals.
Issues affecting hospital systems, including delivery system reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SECTION 508 COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Seeking to advance legislative and regulatory changes to extend geographic classifications established under Section 508 of the Medicare Modernization Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL SISTERS HEALTH SYSTEM via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Issues affecting hospital systems, including delivery system reform.
Issues affecting hospital systems, including delivery system reform and Medicare reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHLAND via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Health information technology issues Medicare payments to hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests.
FDA regulation of laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2013 · first_quarter · Q1
FDA regulation of laboratory-developed tests.
Issues concerning regulation of laboratory tests.
Issues concerning Medicare reimbursement for advanced diagnostic laboratory tests and section 3113 of the Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MEDICARE DEPENDENT RURAL HOSPITAL COAILTION via MCDERMOTT WILL & SCHULTE LLP
2012 · fourth_quarter · Q4
Advocacy on Medicare reimbursement for Medicare dependent rural hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION via MCDERMOTT WILL & SCHULTE LLP
2012 · fourth_quarter · Q4
Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program.
Seeking legislative and regulatory changes that would improve Medicare reimbursement to hospitals with RRC and SCH status.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TRINITY HEALTH via MCDERMOTT WILL & SCHULTE LLP
2012 · fourth_quarter · Q4
Issues affecting hospital systems, including delivery system reform.
Medicare and Medicaid payments to hospitals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE